Welcome to the latest edition of the RWE4Decisions newsletter!
As we head into the final stretch of summer, we’re excited to share key updates from our multi-stakeholder Learning Network. From advancing Stakeholder Actions to deepening our Post-Launch Evidence Generation (PLEG) dialogue, this issue highlights our collective efforts to strengthen the role of real-world evidence (RWE) in HTA and Payer decision-making. Stakeholder Actions in IJTAHC […]
RWE4Decisions: 2024 in review and looking forward to 2025
Dear RWE4Decisions Learning Network, The new year officially marks the beginning of European collaboration under the EU HTA Regulation, with new oncology medicines and ATMPs undergoing Joint Clinical Assessments. Given the often limited clinical evidence available for these innovative treatments, the use of Real-World Evidence (RWE) becomes increasingly relevant. As in previous years, RWE4Decisions will continue to […]
Co-Creation of Real-World Evidence for Decision-Making
Co-Creation of Real-World Evidence for Decision-Making 2022 Symposium on ‘Policies & Partnerships’ Brussels, 24 November 2022: RWE4Decisions welcomes the new momentum to support the development and use of Real-World Evidence (RWE). This is particularly relevant in light of the implementation of the EU Regulation on Health Technology Assessment. Oncology and ATMP products will be assessed […]
RWE4Decisions response to the European Commission Consultation on a European Health Data Space
RWE4Decisions welcomes the European Commission’s proposal for a European Health Data Space (EHDS): it is an ambitious step forward to systematically organise health data in Members States according to aligned, stringent quality standards; with structures to enable well-governed access to data that could improve patient care, support research and innovation and inform policy. The EHDS […]
RWE4Decisions welcomes the proposal for a European Health Data Space
RWE4Decisions welcomes the proposal for a European Health Data Space (EHDS), an ambitious step forward to facilitate the exchange and access to health data in the EU, which will deliver value to patients and to healthcare systems. The EHDS is a major opportunity as it will promote trust in health data through the creation of […]
RWE4Decisions Quarterly Newsletter (September 2021)
Please find the September edition of the quarterly Newsletter here. If you have any news, relevant policy developments or events which you would like to share and promote in the next Newsletter coming out in September, please send it by 15 September to: secretariat@rwe4decisions.com
RWE4Decisions Quarterly Newsletter (June 2021)
Please find the June edition of the quarterly Newsletter here. If you have any news, relevant policy developments or events which you would like to share and promote in the next Newsletter coming out in September, please send it by 15 September to: secretariat@rwe4decisions.com
RWE4Decisions Quarterly Newsletter (March 2021)
Please find the first edition of the quarterly Newsletter here. If you have any events, updates, which you would like to share and promote in the next Newsletter coming out in June, please send it to: secretariat@rwe4decisions.com
EMA/ Payer meeting on evidence generation along the life-cycle of medicinal products
Health care Payers and the European Medicines Agency met on 12 March 2021 to discuss synergies and cultivate mutual understanding and cooperation on evidence generation along the life-cycle of medicinal products. Addressing gaps in evidence generation is particularly important when it comes to highly innovative technologies, as these often come with a higher level of uncertainty regarding safety and […]
RWE4Decisions submission to the Roadmap for a European Health Data Space public consultation
On 23 December 2020, the European Commission launched a public consultation on its Roadmap for the set-up of the European Health Data Space (EHDS). Given the importance of a functioning EHDS to enable the cross-border sharing of real-world data by decision-makers (HTA, payers, regulators), RWE4Decisions provided a response to the consultation. The submission is available online here or here.